Nu Skin Enterprises, Inc. offered an optimistic growth outlook and provided visibility into its direct-sales models in different markets around the globe in a recent investor presentation, following allegations of illegal operations in China, among other ethical and regulatory violations.
Short-seller Citron Research, which prides itself on its “track record identifying fraud and terminal business models,” published a blog post Aug